Fentanyl Addiction | Part Two
CRANDALL/SEAGOVILLE — Sienna was 16. Her family says she took what she believed was a Percocet to relax in her bedroom. The pill contained fentanyl. She died on February 19, 2023.
The Plano teenager’s account, published by her family through Texas Against Fentanyl, describes a student involved in cheer and Girl Scouts.
It does not establish a history of addiction or a prescription following an injury. Calling her death the inevitable conclusion of addiction would misrepresent her story.
That distinction should shape conversations in Crandall and Seagoville homes: some young people develop a substance use disorder over time.
Others encounter a lethal counterfeit pill before adults recognize any continuing pattern of drug use. Prevention has to reach both.
Two routes that must not be confused
Prescription-related addiction is real. It is also not the explanation for every fentanyl death.
In the CDC’s published recovery account, David received opioids after multiple knee surgeries at age 39. He had a prior substance-use history.
He began taking more than prescribed, eventually turned to heroin and experienced devastating losses before finding recovery and becoming a recovery coach.
This is a national example, not a verified Seagoville or Crandall patient.
It illustrates a pathway that deserves attention after an injury: pain treatment can become entangled with escalating use, cravings and difficulty stopping.
A prescription does not remove the need for follow-up, especially when other risk factors exist.
But physical dependence and addiction are not interchangeable.
CDC diagnostic guidance states that tolerance and withdrawal alone do not count toward opioid use disorder criteria when opioids are taken solely under appropriate medical supervision.
Opioid use disorder involves a problematic pattern causing clinically significant impairment or distress.
That distinction protects patients from being mislabeled and helps families recognize the behaviors that need professional assessment.
Someone who needs an individualized taper is not automatically someone buying illicit drugs. Someone repeatedly losing control of use needs more than a lecture about willpower.
What injury research actually found
A study of adolescent trauma patients published in 2019 found that more than 20 percent filled more than two opioid prescriptions in the year after discharge.
More than 13 percent had received more than eight fills by four years.
These are prescription-use findings from a studied population, not evidence that those percentages became addicted.
They cannot be converted into a count of addicted Crandall athletes or Seagoville students.
They do make follow-up a reasonable question for parents: who will reassess the pain, how long is the medication expected to be needed, and what happens if use continues?
Families should discuss those questions with the prescribing clinician rather than decide on an abrupt stop themselves.
CDC’s adult prescribing guideline warns against policies that lead to rapid tapering or abrupt discontinuation.
The point is to treat pain responsibly while keeping the patient connected to care.
The counterfeit pill is a different threat
Pharmaceutical fentanyl has legitimate roles in surgery and severe-pain treatment.
CDC links most fentanyl-related harms to illegally manufactured fentanyl, which can appear in powder or counterfeit pills resembling oxycodone or alprazolam.
It can also be mixed with heroin, cocaine or methamphetamine without the person knowing.
An illicit pill’s familiar appearance can therefore provide reassurance that its contents do not deserve.
Parents discussing this danger should explain the distinction between medicine dispensed for a patient by a licensed pharmacy and a pill obtained from a friend or informal seller.
North Texas has already seen how quickly the danger can spread among children.
In a May 2024 sentencing announcement, federal prosecutors described a Carrollton fentanyl case involving 14 juvenile overdoses, four fatal, with victims as young as 13.
The numbers describe an emergency affecting multiple households, not a basis for assuming every young person involved had the same history or diagnosis.
The student who survives is still in danger
The book opens with Mackenzie, a composite teenager found unconscious in a school bathroom. Another student discovers her.
Adults rush to respond. She survives the overdose, but the narrative does not end with the ambulance leaving campus.
Her family struggles to connect her with care, and another overdose follows.
This is an illustrative story, not a reported incident at Crandall High School or a Seagoville campus.
Its most useful question comes after the dramatic rescue: who becomes responsible for making sure a surviving student receives help?
A school can have an emergency response plan while a family still faces a separate struggle to arrange assessment and ongoing treatment.
The person who responds to the overdose may not be the person who can schedule care.
A parent may receive information without knowing which service is appropriate for a minor. A student may fear that asking for help will become another story circulating among classmates.
Those are issues local leaders should test against their actual procedures, rather than assume a stocked cabinet resolves.
Families should be able to learn who coordinates the next step, what information remains private and how the school supports a return to class.
An overdose survivor is still a student with an education to continue.
The composite also challenges the idea that the emergency belongs only to the person who takes the pill.
Another child makes the discovery. Staff members become responders. Classmates see an ambulance and may hear conflicting accounts.
An effective response should include accurate communication and a way for frightened students to seek support without turning the affected child into a spectacle.
Pain deserves care, and questions deserve answers
For parents of an injured teenager, the immediate concern is often getting their child comfortable enough to sleep, move and recover.
A warning about addiction should not imply that seeking pain relief was the mistake.
The more useful question is how the family and clinician will recognize when the original treatment plan needs reassessment.
Before leaving an appointment, a parent can ask the prescriber to explain the expected course of pain, the role of each medication and whom to contact if the plan is not working.
If medication use changes, that change belongs in a clinical conversation. Families should not have to choose between concealing a concern and accusing their child of addiction.
For teenagers, the distinction between a prescription and an informal pill offer needs to be explicit. The same name spoken by a friend does not establish the same product.
A pill offered as a remedy for stress is not made safe by the fact that the seller is another student.
CDC’s counterfeit-pill warning applies to the source and contents, not to how trustworthy the person offering it seems.
The two stories in this article lead to different prevention work. David’s account points toward careful care over time.
Sienna’s points toward a dangerous exposure that need not be preceded by a recognizable history of addiction.
Neither story supports waiting until a teenager looks like an adult’s stereotype of a person using drugs.
For Crandall and Seagoville families, the opening question can be simple: if a pill worried you, or a friend stopped responding, which adult would you tell?
The answer matters more than a promise that such a situation could never happen.
A school plan must work after class
Crandall ISD says naloxone is available at every campus and its nursing staff and district officers have been trained to administer it.
The district also says opioid-overdose management is part of its emergency response plan. That is a concrete local safeguard.
Parents can ask how it operates during extracurricular activities, who responds when the nurse is unavailable and how an affected student is connected to care afterward.
Those are implementation questions; the published policy alone does not answer all of them.
A useful family conversation leaves room for a teenager to admit a mistake, describe pressure from friends or ask for help with pain without first proving that the situation has become disastrous.
Adults can be firm about dangerous pills and still make that admission possible.
Sienna’s family shared her story to help other families speak before a loss. The opening for that conversation should not depend on a child already meeting a diagnosis of addiction.
